Diabetes and osteoporosis: Action of gastrointestinal hormones on the bone.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Revista clínica española (Ed. impresa)

• Publication date

  2013-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.rce.2013.01.014PMID 26530941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• [Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Bone Metabolism Working Group of the Spanish Society of Endocrinology].

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• Manejo de la hiperglucemia en el paciente hospitalizado no crítico con alimentación oral

  2012cited by this paper
• Guías de práctica clínica para la evaluación y tratamiento de la osteoporosis asociada a enfermedades endocrinas y nutricionales

  2012cited by this paper
• Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice.

  2012cited by this paper
• FRAX underestimates fracture risk in patients with diabetes

  2012cited by this paper
• [Management of hyperglycemia in the non-critical hospitalized patients with oral feeding].

  2012cited by this paper
• [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].

  2011cited by this paper
• Review: The Diabetic Bone: A Cellular and Molecular Perspective

  2011cited by this paper
• Executive Summary: Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures

  2011cited by this paper
• Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes.

  2011cited by this paper
• GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia.

  2011cited by this paper
• Impaired regulation of the incretin effect in patients with type 2 diabetes.

  2011cited by this paper
• Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement

  2011cited by this paper
• Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes

  2011cited by this paper
• Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus

  2010cited by this paper
• [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].

  2010cited by this paper
• Pleiotropic actions of the incretin hormones.

  2010cited by this paper
• Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.

  2010cited by this paper
• Presence of a functional receptor for GLP‐1 in osteoblastic cells, independent of the cAMP‐linked GLP‐1 receptor

  2010cited by this paper
• Escalas de riesgo de osteoporosis. La herramienta FRAX

  2009cited by this paper
• Role of oxidative stress in diabetic bone disorder.

  2009cited by this paper
• Vertebral fractures in males with type 2 diabetes treated with rosiglitazone.

  2009cited by this paper
• Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States

  2009cited by this paper
• Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications

  2009cited by this paper
• Osteocalcin differentially regulates β cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice

  2008cited by this paper
• Rosiglitazone-Associated Fractures in Type 2 Diabetes

  2008cited by this paper
• Osteoporosis among patients with type 1 and type 2 diabetes.

  2008cited by this paper
• Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral

  2008cited by this paper
• Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference.

  2008cited by this paper
• Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

  2008cited by this paper
• The murine glucagon-like peptide-1 receptor is essential for control of bone resorption.

  2008cited by this paper
• Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis

  2007cited by this paper
• Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis

  2007cited by this paper
• Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.

  2007cited by this paper
• Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference.

  2006cited by this paper
• Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk

  2005cited by this paper
• Advanced Glycation End Products and Bone Loss during Aging

  2005cited by this paper
• Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial.

  2004cited by this paper
• Expression of glucagon‐like peptide 1 receptor in a murine C cell line Regulation of calcitonin gene by glucagon‐like peptide 1

  1996cited by this paper
• Advanced protein glycosylation in diabetes and aging.

  1995cited by this paper
• Diminished Bone Formation in Experimental Diabetes: Relationship to Osteoid Maturation and Mineralization

  1984cited by this paper

• Meta-Analysis of the Efficacy and Safety of Alendronate Combined with Atorvastatin in the Treatment of Osteoporosis in Diabetes Mellitus

  2022cites this paper
• Osteoporosis and Hepatic Steatosis: 2 Closely Related Complications in Short-Bowel Syndrome.

  2020cites this paper
• Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial

  2020cites this paper
• In Silico Interaction of the Active Compounds of Scurrula Atropurpurea with the RANK/RANKL/OPG System in Diabetoporosis

  2019cites this paper
• Short bowel syndrome: influence of nutritional therapy and incretin GLP1 on bone marrow adipose tissue

  2018cites this paper
• Assessment of effects of ultrasound therapy on reduction of pain in gonarthrosis.

  2014cites this paper